Log in

OTCMKTS:HSTCHST Global Stock Price, Forecast & News

$0.05
0.00 (0.00 %)
(As of 07/3/2020 04:00 PM ET)
Add
Compare
Today's Range
$0.05
Now: $0.05
$0.05
50-Day Range
$0.05
MA: $0.07
$0.08
52-Week Range
$0.05
Now: $0.05
$0.24
Volume830 shs
Average Volume1,479 shs
Market Capitalization$217,175.00
P/E RatioN/A
Dividend YieldN/A
Beta1.42
HST Global, Inc., an integrated health and wellness biotechnology company, develops and/or acquires a network of wellness centers for the homeopathic and alternative treatment of late stage cancer worldwide. It also focuses on the homeopathic and alternative product candidates that are undergoing or have already completed clinical testing for the treatment of late stage cancers and other life threatening diseases. The company also intends to acquire products for the treatment of individual health challenges. HST Global, Inc. is headquartered in Hampton, Virginia.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.70 out of 5 stars


Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:HSTC
CUSIPN/A
Phone757-766-6100

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Net Income$430,000.00

Miscellaneous

EmployeesN/A
Market Cap$217,175.00
Next Earnings DateN/A
OptionableNot Optionable

Receive HSTC News and Ratings via Email

Sign-up to receive the latest news and ratings for HSTC and its competitors with MarketBeat's FREE daily newsletter.

HST Global (OTCMKTS:HSTC) Frequently Asked Questions

How has HST Global's stock been impacted by COVID-19 (Coronavirus)?

HST Global's stock was trading at $0.09 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, HSTC shares have decreased by 43.2% and is now trading at $0.0511. View which stocks have been most impacted by Coronavirus.

How were HST Global's earnings last quarter?

HST Global Inc (OTCMKTS:HSTC) issued its earnings results on Monday, November, 20th. The company reported $0.00 earnings per share for the quarter. View HST Global's earnings history.

Has HST Global been receiving favorable news coverage?

News articles about HSTC stock have been trending negative this week, according to InfoTrie. The research firm identifies positive and negative press coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. HST Global earned a media sentiment score of -2.2 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 5.0 out of 10, meaning that recent press coverage is somewhat likely to have an impact on the company's share price in the next few days. View the latest news about HST Global.

Who are some of HST Global's key competitors?

What other stocks do shareholders of HST Global own?

Who are HST Global's key executives?

HST Global's management team includes the following people:
  • Mr. Ronald R. Howell, Chairman, CEO, Pres & Interim CFO (Age 71)

What is HST Global's stock symbol?

HST Global trades on the OTCMKTS under the ticker symbol "HSTC."

How do I buy shares of HST Global?

Shares of HSTC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is HST Global's stock price today?

One share of HSTC stock can currently be purchased for approximately $0.05.

How big of a company is HST Global?

HST Global has a market capitalization of $217,175.00.

What is HST Global's official website?

The official website for HST Global is www.hstglobal.com.

How can I contact HST Global?

HST Global's mailing address is 150 RESEARCH DR., HAMPTON VA, 23666. The company can be reached via phone at 757-766-6100.

This page was last updated on 7/5/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.